Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease

N Korte, R Nortley, D Attwell - Acta neuropathologica, 2020‏ - Springer
Therapies targeting late events in Alzheimer's disease (AD), including aggregation of
amyloid beta (Aβ) and hyperphosphorylated tau, have largely failed, probably because they …

[HTML][HTML] How does neurovascular unit dysfunction contribute to multiple sclerosis?

JM Cashion, KM Young, BA Sutherland - Neurobiology of Disease, 2023‏ - Elsevier
Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system
(CNS) and the most common non-traumatic cause of neurological disability in young adults …

Optical coherence tomography angiography (OCTA) in multiple sclerosis and neuromyelitis optica spectrum disorder

I Kleerekooper, S Houston, AM Dubis, SA Trip… - frontiers in …, 2020‏ - frontiersin.org
Vascular changes are increasingly recognized as important factors in the pathophysiology of
neuroinflammatory disease, especially in multiple sclerosis (MS). The relatively novel …

Nimodipine protects vascular and cognitive function in an animal model of cerebral small vessel disease

Z Yang, F Lange, Y **a, C Chertavian, K Cabolis… - Stroke, 2024‏ - ahajournals.org
BACKGROUND: Cerebral small vessel disease is a common cause of vascular cognitive
impairment and dementia. There is an urgent need for preventative treatments for vascular …

From BBB to PPP: Bioenergetic requirements and challenges for oligodendrocytes in health and disease

MGF Fernandes, F Pernin, JP Antel… - Journal of …, 2025‏ - Wiley Online Library
Mature myelinating oligodendrocytes, the cells that produce the myelin sheath that insulates
axons in the central nervous system, have distinct energetic and metabolic requirements …

Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis

N Cunniffe, KA Vuong, D Ainslie, D Baker… - Journal of Neurology …, 2021‏ - jnnp.bmj.com
Objective To establish a rigorous, expert-led, evidence-based approach to the evaluation of
licensed drugs for repurposing and testing in clinical trials of people with progressive …

Deletion of voltage-gated calcium channels in astrocytes decreases neuroinflammation and demyelination in a murine model of multiple sclerosis

GE Denaroso, Z Smith, CG Angeliu, VT Cheli… - Journal of …, 2023‏ - Springer
The experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis was
used in combination with a Cav1. 2 conditional knock-out mouse (Cav1. 2KO) to study the …

Tissue hypoxia and associated innate immune factors in experimental autoimmune optic neuritis

Z Yang, C Marcoci, HK Öztürk, E Giama… - International Journal of …, 2024‏ - mdpi.com
Visual loss in acute optic neuritis is typically attributed to axonal conduction block due to
inflammatory demyelination, but the mechanisms remain unclear. Recent research has …

Investigating cortical hypoxia in multiple sclerosis via time‐domain near‐infrared spectroscopy

T Williams, F Lange, KJ Smith… - Annals of Clinical …, 2024‏ - Wiley Online Library
Objectives Hypoperfusion and tissue hypoxia have been implicated as contributory
mechanisms in the neuropathology of multiple sclerosis (MS). Our objective has been to …